Clinical Trials
15 trialsNCT07526961 2026-04-14
Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland
Bristol-Myers Squibb
Completed
NCT06504615 2026-04-03
METAGIO
Bristol-Myers Squibb
Active not recruiting
NCT04943497 2026-04-01
PROSPERITY
Novartis
Completed
NCT07215962 2025-10-14
Long-Term Safety Outcomes and First-Line Treatment Patterns in Patients With Non-Small Cell Lung Cancer and Programmed Death-1 (Pd-L1) <1%
Bristol-Myers Squibb
Active not recruiting
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT04638751 2024-04-05
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients
Persephone Biosciences
Unknown
NCT01732783 2022-11-08
Observational Study of Vectibix With Chemotherapy for Metastatic Colorectal Cancer Patients
Amgen
Completed
NCT03521245 2021-09-14
Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer
OmicsWay Corp.
Unknown
NCT02305615 2018-08-23
AVACONT
Hoffmann-La Roche
Completed
NCT01712347 2018-07-31
An Observational Study of First-Line Bevacizumab (Avastin) With Fluoropyrimidine-Based Chemotherapy in Participants With Metastatic Colorectal Cancer
Hoffmann-La Roche
Completed
NCT02831842 2018-01-26
A Real World Study to Evaluate Effectiveness of Avastin (Bevacizumab) for First Line Treatment of Patients With Metastatic Colorectal Cancer and Known KRAS Status
Hoffmann-La Roche
Completed
NCT02472756 2017-08-01
REFLECT 2
Hoffmann-La Roche
Completed
NCT01696695 2017-03-23
AXEL
Hoffmann-La Roche
Completed
NCT01224093 2016-11-02
An Observational Study on the Safety Profile of MabThera/Rituxan (Rituximab) in Combination With Chemotherapy in Patients With B Cell-lineage Chronic Lymphocytic Leukaemia (MABERYC)
Hoffmann-La Roche
Completed
NCT02461290 2015-09-30
Rituximab Therapy in Follicular Lymphoma in Combination With Chemotherapy - REFLECT 1
Hoffmann-La Roche
Completed